4 Einträge gefunden

1. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

   1. Mateos, Maria-Victoria
   2. Weisel, Katja
   3. De Stefano, Valerio
   4. Goldschmidt, Hartmut
   5. Delforge, Michel
   6. Mohty, Mohamad
   7. Cavo, Michele

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. MM-183 CARTITUDE-2 Cohort A: Updated Clinical Data and Biological Correlative Analyses of Ciltacabtagene Autoleucel (cilta-cel) in Lenalidomide-Refractory Patients With Progressive Multiple Myeloma (MM) After 1-3 Prior Lines of Therapy (LOT)

   1. Hillengass, Jens
   2. Cohen, Adam D
   3. Delforge, Michel
   4. Einsele, Hermann
   5. Goldschmidt, Hartmut
   6. Weisel, Katja
   7. Raab, Marc-Steffen

   2022 - Forschungsinformationssystem des UKE
3. Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma

   1. Rodriguez-Otero, Paula
   2. Ayers, Dieter
   3. Cope, Shannon
   4. Davies, Faith E
   5. Delforge, Michel
   6. Mojebi, Ali
   7. Jansen, Jeroen P

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR

   1. Weisel, Katja
   2. Mateos, Maria-Victoria
   3. Gay, Francesca
   4. Delforge, Michel
   5. Cook, Gordon
   6. Szabo, Zsolt
   7. Desgraz, Renaud

   2021 - Forschungsinformationssystem des UKE - frei zugänglich